Skip to main content
Log in

Caffey disease responding to high-dose immunoglobulin

  • Letters to the Editors
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Furusho K, Nakano H, Shinomiya K, Tamura T, Manabe Y, Kawarano M, Baba K, Kamiya T, Kiyosawa H, Hayashiedera T, Hirose O, Yokoyama T, Baba K, Mori C (1984) High dose intravenous gammaglobulin for Kawasaki disease. Lancet II:1055–1058

    Google Scholar 

  2. Huret JL, Delabar JM, Marlhens F, Aurias A, Nicole A, Berthier M, Tanzer J, Sinet PM (1987) Down syndrome with duplication of a region of chromosome 21 containing the CuZn superoxide dismutase gene without detectable karyotypic abnormality. Hum Genet 75:251–257

    Google Scholar 

  3. Imbach P, D'Appuzo V, Hirt A, Rossi E, Vest M, Baradun S, Baumgartner C, Morell A, Schoni M, Wagner HP (1981) High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet II:1228–1231

    Google Scholar 

  4. Mc Emery G, Nash FW (1973) Wiskott Aldrich syndrome associated with idiopathic cortical hyperostosis. Arch Dis Child 48:818–821

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berthier, M., Bonneau, D. & Huret, J.L. Caffey disease responding to high-dose immunoglobulin. Eur J Pediatr 147, 443–444 (1988). https://doi.org/10.1007/BF00496434

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00496434

Keywords

Navigation